Tesla surges, Macy's beats, tariffs loom

🌅 Today's Morning Call

S&P Futures 7,617.00 ▼ -6.50 (-0.09%)	Nasdaq Futures 30,781.25 ▲ +74.00 (+0.24%)	Dow Futures 51,262.00 ▼ -116.00 (-0.23%)
10Y Treasury 4.45% ▼ -0.02%	US Dollar 99.32 ▲ +0.07 (+0.07%)	Bitcoin $66,969 ▲ +$312 (+0.47%)

Good morning! It is Wednesday, June 3, 2026, and the market is giving us a classic split-screen morning. Nasdaq futures are holding green while the Dow and S&P drift slightly lower, which tells you exactly where the energy is right now: tech is leading, everything else is waiting. Tesla, Eli Lilly, and Macy's are all flashing headlines before the bell, so there is plenty to work through this morning.

👀 What to Watch Today

The macro backdrop is your first checkpoint today. Treasury yields are nudging lower across the curve, with the 10-year sitting at 4.45% and the 30-year just under 5% at 4.97%. That mild pullback in yields is giving Nasdaq futures a bit of room to breathe, and it explains why growth names are outperforming this morning while rate-sensitive plays stay flat.

On the tariff front, the Trump administration is signaling new forced-labor tariffs that would replace existing ones as soon as the current measures expire. That is a headline worth tracking closely because it has direct implications for supply chains across retail, industrials, and consumer goods. European shares are already pricing in some pain from a separate proposed EU tariff, with futures across the continent pointing lower.

Also watch the dollar today. DXY is ticking up slightly to 99.32, which historically creates a headwind for multinationals reporting overseas revenue. Companies like MDT and NVO, both in focus today, derive significant international sales, so currency moves matter more than usual this session.

Forget Amazon's 1997 IPO... This Could Be 287 Times Bigger [ad]

🌏 Overnight Recap

Overnight in Asia, the EV story dominated. Tesla reported that its Shanghai Gigafactory delivered 85,982 vehicles in May, a roughly 40% jump that signals genuine demand recovery in China's domestic market. That is not a rounding error. China's broader EV sector also posted strong numbers, with domestic manufacturers moving 1.36 million passenger EVs in May, up 12% year over year. TSLA is responding in pre-market.

In Europe, Finnish elevator giant Kone cleared a major hurdle when its shareholders voted to approve the $34 billion acquisition of German competitor TK Elevator. That deal would create the world's largest elevator company, reshuffling competitive dynamics across global infrastructure and construction. KNYJF and KNYJY are worth a look for anyone tracking global industrials.

Novo Nordisk made a quiet but significant move overnight, launching its Wegovy weight-loss pill in the United Arab Emirates. This is the first time the oral version of the drug has been introduced outside the United States, marking an early test of international appetite for the pill format. NVO investors will be watching closely to see if this builds momentum for a broader global rollout.

The Death of the Nasdaq? [ad]

📊 Pre-Market Movers

TSLA is the headliner in pre-market. The 40% surge in China-made EV deliveries for May is exactly the kind of hard data point that shifts sentiment quickly on a stock that lives and dies by demand signals. After a rough stretch for Musk-related headlines, this is a tangible positive.

LLY is also getting attention. A licensing agreement valued at up to $1.9 billion with Ascidian Therapeutics gives Eli Lilly access to RNA-editing technology aimed at rare inherited kidney diseases. Gene-editing deals at this price tag signal serious commitment to a pipeline category that has become a battleground for large-cap pharma.

On the downside, F is dealing with a recall of nearly 420,000 vehicles over seat-belt retraction issues flagged by NHTSA. Recalls of this scale rarely crater a stock outright, but they add noise to an already complicated macro picture for the automaker. Keep an eye on how the market weighs that against the broader EV sector momentum playing out this morning.

What is "Project Apex"? [ad]

🔍 Today's Watchlist

1. TSLA: China May delivery numbers are in. Does the pre-market pop hold once U.S. trading opens?
2. LLY: A $1.9 billion gene-editing licensing deal with Ascidian Therapeutics puts Lilly squarely in the rare kidney disease race.
3. M: Macy's best Q1 comparable sales growth in four years and a raised forecast deserve attention in retail today.
4. MDT: Medtronic topped quarterly estimates on strong heart device demand. Watch for any analyst price target revisions.
5. Tariff tape: New forced-labor tariff language from the White House could move names across retail, apparel, and industrials fast.

🎯 The Morning Playbook

The playbook for today is pretty straightforward: follow the tech bid and stay alert on the tariff tape. Nasdaq futures are outperforming because yields are cooperating and EV optimism is real. If that yield dip holds through the morning, growth names have a genuine tailwind worth leaning into.

The wildcard is policy. New tariff language targeting forced-labor goods could land at any point and shift the mood quickly across retail and industrials. Macy's raised its forecast and posted strong comps, which is encouraging for consumer sentiment, but any fresh trade friction could test that optimism fast.

Bitcoin is quietly holding above $66,900, the dollar is nudging higher, and treasury yields are soft. That combination historically favors tech and growth over value and cyclicals for at least the first half of the session. Stay nimble, watch the headlines, and remember that the best trades today may come from stories that are already in plain sight.

Why BlackRock is buying this "Penny Stock" [ad]